Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
published in: Anticancer Research
date of publication: 2019-09-01
Cites articles
There is nothing here
Article - wd:Q90099562